Advertisement
Canada markets close in 27 minutes
  • S&P/TSX

    21,969.32
    +83.94 (+0.38%)
     
  • S&P 500

    5,109.23
    +60.81 (+1.20%)
     
  • DOW

    38,283.62
    +197.82 (+0.52%)
     
  • CAD/USD

    0.7319
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    83.71
    +0.14 (+0.17%)
     
  • Bitcoin CAD

    87,252.44
    -1,114.87 (-1.26%)
     
  • CMC Crypto 200

    1,332.37
    -64.16 (-4.59%)
     
  • GOLD FUTURES

    2,348.30
    +5.80 (+0.25%)
     
  • RUSSELL 2000

    2,002.92
    +21.80 (+1.10%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,959.20
    +347.44 (+2.23%)
     
  • VOLATILITY

    14.98
    -0.39 (-2.54%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

GlaxoSmithKline’s HIV Business in 3Q17

GlaxoSmithKline’s (GSK) HIV business includes products such as Triumeq, Tivicay, Epzicom/Kivexa, and Selzentry.